Related Experiment Videos
The universality of bioenergetic disease and amelioration with redox therapy
A W Linnane1, M Degli Esposti, M Generowicz
1Centre for Molecular Biology and Medicine, Monash University, Melbourne, Victoria, Australia.
Abstract:
Overt mitochondrial diseases associated with mitochondrial DNA mutations are characterized by a decline in mitochondrial respiratory function. Similarly, a progressive decline in mitochondrial respiratory function associated with mitochondrial DNA mutations is clearly evidenced in aged human subjects. This communication is concerned with the development of a rat model for the study of bioenergy decline associated with the ageing process and overt mitochondrial diseases. The model involves the treatment of young rats with AZT to induce skeletal and cardiac myopathies. It has shown that there is a decline in soleus muscle function in vivo and that this decline is mirrored in the capacity of heart sub-mitochondrial particles to maintain bioenergy function. Coenzyme Q10 and several analogs were administered with AZT as potential therapeutics for the re-energization of affected tissues. Coenzyme Q10 and especially decyl Q were found to be therapeutically beneficial by both in vivo improvement in soleus muscle function and in vitro cardiac mitochondrial membrane potential capacity. Sub-mitochondrial particles were also prepared from heart mitochondria of young and aged rats. The particles prepared from the aged rats were found to have a decreased ability to maintain membrane potential as compared to those derived from the young rats.
Insights
A new rat model mimics age-related mitochondrial decline and disease. AZT treatment induced myopathies, while Coenzyme Q10 and decyl Q showed therapeutic benefits for bioenergy restoration.
Area of Science:
- Biochemistry
- Mitochondrial Biology
- Aging Research
Background:
- Mitochondrial DNA mutations cause respiratory decline in diseases and aging.
- Understanding bioenergy decline is crucial for treating mitochondrial diseases and age-related conditions.
Purpose of the Study:
- To develop a rat model simulating bioenergy decline in aging and mitochondrial diseases.
- To investigate the therapeutic potential of Coenzyme Q10 and its analogs.
Main Methods:
- Young rats were treated with AZT to induce skeletal and cardiac myopathies.
- In vivo soleus muscle function and in vitro heart mitochondrial bioenergetics were assessed.
- Coenzyme Q10 and analogs were administered as potential therapeutics.
- Sub-mitochondrial particles from young and aged rats were analyzed.
Main Results:
- AZT treatment led to decreased soleus muscle function and impaired heart mitochondrial bioenergetics.
- Coenzyme Q10 and decyl Q improved soleus muscle function and mitochondrial membrane potential.
- Aged rat heart mitochondria exhibited reduced membrane potential capacity compared to young rats.
Conclusions:
- The AZT-treated rat model effectively replicates bioenergy decline seen in aging and mitochondrial disease.
- Coenzyme Q10 and decyl Q demonstrate therapeutic potential for restoring mitochondrial function.
- Age-associated decline in mitochondrial membrane potential is confirmed.